Rita F Redberg
Biographic Data
| ID | 5537906 |
|---|---|
| NAME | Rita F Redberg |
| GIVEN NAMES | Rita F |
| FAMILY NAME | Redberg |
| SIGNATURE | REDBERG R F |
| AFFILIATIONS | University of California, San Francisco |
| ORCID | 0000-0001-6281-0250 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Health Professional Students’ Knowledge About FDA Drug and Medical Device Regulation
Evaluation of Payer Policies to Reduce Low-Value Medical Device–Based Procedure Use
In this quality improvement study, enactment of evidence-based clinical coverage policies for 4 common medical device-based procedures was not associated with a reduction in their use in Louisiana Medicaid. These findings suggest a need for more comprehensive strategies to improve evidence-based care for Medicaid through multipronged efforts that include education, policymaking, and value-based coverage implementation
The Origins of Regulations for Pharmaceutical Products and Medical Devices – What Can be Learned for the Governance of Medical Devices in Europe
Regulations are necessary for the governance of health products in order to protect public health and safely introduce new technologies. This article examines the history of regulations in the USA and EU for food, medicines and medical devices, to uncover the original motivations and objectives for legislative initiatives. The foundation of the US FDA in the early twentieth century resulted from concerns about adulteration of foods. Drug regulati…
A Critical Examination of Independent Medical Review Decision-making for Cardiovascular Procedures Shows Low Rate of Evidence Citation in Reviews
BACKGROUND: The California Independent Medical Review (IMR) program was created in 2001 to provide an independent, external evaluation of insurers' denials of coverage of health services. OBJECTIVE: We sought to evaluate the quality and comprehensiveness of data used to support IMR decision-making between 2015 and 2020. RESULTS: Of the 159 cases submitted to IMR regarding denials of cardiovascular procedures, 52% of these denials were overturned …
Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the Jama Network
Timely access to scientific research findings for the broadest possible audience is a principle on which sound science is based. Access to new findings helps other scientists adjust their hypotheses and open new lines of inquiry, thereby supporting and accelerating further discovery and innovation. For those who rely on newly generated evidence to develop policies and define practices that improve medicine and public health, rapid and equitable a…
Is the FDA Failing Women
Many devices in current use were marketed before the US Food and Drug Administration (FDA) began regulating devices in 1976. Thus, manufacturers of these devices were not required to demonstrate safety and effectiveness, which presents both clinical and ethical problem for patients, especially for women, as some of the most dangerous devices-such as implanted contraceptive devices-are used only in women. This article investigates whether and to w…
The Risk of Remaining Silent
Impact of Changes in Clinical Practice Guidelines on Assessment of Quality of Care
BACKGROUND: Measures for pay-for-performance and public reporting programs may be based on clinical practice guidelines. The impact of guideline changes over time-and whether evolving clinical evidence can render measures based on prior guidelines misleading-is not known. OBJECTIVE: To assess the impact of using different percutaneous coronary intervention (PCI) guidelines when evaluating whether PCI was indicated. RESEARCH DESIGN: PCIs from the …
No prominent works on this page.
Impact of Changes in Clinical Practice Guidelines on Assessment of Quality of Care
BACKGROUND: Measures for pay-for-performance and public reporting programs may be based on clinical practice guidelines. The impact of guideline changes over time-and whether evolving clinical evidence can render measures based on prior guidelines misleading-is not known. OBJECTIVE: To assess the impact of using different percutaneous coronary intervention (PCI) guidelines when evaluating whether PCI was indicated. RESEARCH DESIGN: PCIs from the …
The Risk of Remaining Silent
Is the FDA Failing Women
Many devices in current use were marketed before the US Food and Drug Administration (FDA) began regulating devices in 1976. Thus, manufacturers of these devices were not required to demonstrate safety and effectiveness, which presents both clinical and ethical problem for patients, especially for women, as some of the most dangerous devices-such as implanted contraceptive devices-are used only in women. This article investigates whether and to w…
Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the Jama Network
Timely access to scientific research findings for the broadest possible audience is a principle on which sound science is based. Access to new findings helps other scientists adjust their hypotheses and open new lines of inquiry, thereby supporting and accelerating further discovery and innovation. For those who rely on newly generated evidence to develop policies and define practices that improve medicine and public health, rapid and equitable a…
A Critical Examination of Independent Medical Review Decision-making for Cardiovascular Procedures Shows Low Rate of Evidence Citation in Reviews
BACKGROUND: The California Independent Medical Review (IMR) program was created in 2001 to provide an independent, external evaluation of insurers' denials of coverage of health services. OBJECTIVE: We sought to evaluate the quality and comprehensiveness of data used to support IMR decision-making between 2015 and 2020. RESULTS: Of the 159 cases submitted to IMR regarding denials of cardiovascular procedures, 52% of these denials were overturned …
Health Professional Students’ Knowledge About FDA Drug and Medical Device Regulation
Evaluation of Payer Policies to Reduce Low-Value Medical Device–Based Procedure Use
In this quality improvement study, enactment of evidence-based clinical coverage policies for 4 common medical device-based procedures was not associated with a reduction in their use in Louisiana Medicaid. These findings suggest a need for more comprehensive strategies to improve evidence-based care for Medicaid through multipronged efforts that include education, policymaking, and value-based coverage implementation
The Origins of Regulations for Pharmaceutical Products and Medical Devices – What Can be Learned for the Governance of Medical Devices in Europe
Regulations are necessary for the governance of health products in order to protect public health and safely introduce new technologies. This article examines the history of regulations in the USA and EU for food, medicines and medical devices, to uncover the original motivations and objectives for legislative initiatives. The foundation of the US FDA in the early twentieth century resulted from concerns about adulteration of foods. Drug regulati…
Medicine (7 works) · Political science (4 works) · Business (3 works) · Family medicine (3 works) · MEDLINE (3 works) · Alternative medicine (2 works) · Engineering (2 works) · Guideline (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works)